• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有骨转移的前列腺癌患者的腰椎骨密度

Lumbar bone mineral density in prostate cancer patients with bone metastases.

作者信息

Chang Chao-Hsiang, Tsai Chang-Shu, Jim Yick-Fung, Wu Hsi-Chin, Lin Cheng-Chieh, Kao Albert

机构信息

Department of Urology, China Medical College Hospital, Taichung, Taiwan.

出版信息

Endocr Res. 2003 May;29(2):177-82. doi: 10.1081/erc-120022298.

DOI:10.1081/erc-120022298
PMID:12856804
Abstract

UNLABELLED

Because of the discrepant findings on regional bone mineral density (BMD) in stage IV patients with bone metastases due to prostate cancer, we decided to evaluate BMD of lumbar spines in 30 prostate cancer patients with lumbar spine metastases. These measurements of BMD in lumbar spines were compared with 30 stage IV prostate cancer patients without lumbar spine metastases.

METHODS

Before BMD measurements, the bone scan with technetium-99m labeled diphosphonate was carried out in all of the men to evaluate lumbar spine metastases. Dual energy x-ray absorptiometry was used to measure BMD in the lumbar spines.

RESULTS

There was no difference of age, height, weight, and body mass index between the two group patients. However, significantly higher BMD of the lumbar spines in the 30 patients of prostate cancers with lumbar spine metastases was found (p value <0.05).

CONCLUSIONS

Our results show that patients of prostate cancers with lumbar spine metastases demonstrated by Tc-99m MDP bone scan have increased BMD in the lumbar spines, possibly because of a predominance of osteoblastic over osteolytic metastases demonstrated by Tc-99m MDP bone scan.

摘要

未标注

由于前列腺癌导致的骨转移IV期患者区域骨密度(BMD)的研究结果存在差异,我们决定评估30例有腰椎转移的前列腺癌患者的腰椎骨密度。将这些腰椎骨密度测量结果与30例无腰椎转移的IV期前列腺癌患者进行比较。

方法

在进行骨密度测量之前,所有男性均进行了锝-99m标记二膦酸盐骨扫描以评估腰椎转移情况。采用双能X线吸收法测量腰椎骨密度。

结果

两组患者的年龄、身高、体重和体重指数无差异。然而,发现30例有腰椎转移的前列腺癌患者的腰椎骨密度明显更高(p值<0.05)。

结论

我们的结果表明,经锝-99m亚甲基二膦酸盐骨扫描证实有腰椎转移的前列腺癌患者腰椎骨密度增加,可能是因为锝-99m亚甲基二膦酸盐骨扫描显示成骨转移多于溶骨转移。

相似文献

1
Lumbar bone mineral density in prostate cancer patients with bone metastases.伴有骨转移的前列腺癌患者的腰椎骨密度
Endocr Res. 2003 May;29(2):177-82. doi: 10.1081/erc-120022298.
2
Is bone mineral density measurement using dual-energy X-ray absorptiometry affected by gamma rays?双能 X 射线吸收法测量骨密度会受到伽马射线影响吗?
J Clin Densitom. 2013 Jul-Sep;16(3):275-278. doi: 10.1016/j.jocd.2013.02.006. Epub 2013 Mar 7.
3
Quantification evaluation of Tc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density.SPECT/CT 定量评估腰椎 Tc-MDP 浓度:与骨密度比较。
Ann Nucl Med. 2020 Feb;34(2):136-143. doi: 10.1007/s12149-019-01425-x. Epub 2019 Nov 25.
4
Correlation between BMD and bone scintigraphy in patients with prostate cancer.前列腺癌患者骨密度与骨闪烁显像的相关性
Urol Oncol. 2008 May-Jun;26(3):250-3. doi: 10.1016/j.urolonc.2007.05.027. Epub 2007 Dec 3.
5
Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA.先前给予99mTc-亚甲基二膦酸盐和99mTc-甲氧基异丁基异腈会影响通过双能X线吸收法测量的骨密度。
J Clin Densitom. 2006 Apr-Jun;9(2):164-6. doi: 10.1016/j.jocd.2006.01.003. Epub 2006 Apr 18.
6
Effects of 99mTc-MIBI and 99mTc-MDP administration on dual-energy X-ray absorptiometry bone mineral density measurements.99mTc-MIBI和99mTc-MDP给药对双能X线吸收法骨密度测量的影响。
Nucl Med Commun. 2009 Jun;30(6):445-8. doi: 10.1097/MNM.0b013e328329fc4c.
7
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
8
Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by F-FDG PET/CT. The role of Tc-MDP.通过F-FDG PET/CT研究发现,乳腺癌和前列腺癌骨转移灶中的代谢活性相似。锝-亚甲基二膦酸盐(Tc-MDP)的作用。
Hell J Nucl Med. 2017 Sep-Dec;20(3):237-240. doi: 10.1967/s002449910608. Epub 2017 Nov 27.
9
[Bone mineral density change: comparison between prostate cancer patients with or without metastases and healthy men (a North African ethnic group)].
Actas Urol Esp. 2011 Jul-Aug;35(7):414-9. doi: 10.1016/j.acuro.2011.02.007. Epub 2011 May 6.
10
Disappearance of 99mTc-MDP accumulation in metastatic bone disease during bone scintigraphy.
Radiat Med. 1997 Jul-Aug;15(4):235-7.

引用本文的文献

1
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience.唑来膦酸治疗期间评估骨转换标志物和 DXA 参数以预测骨转移进展:一项单中心经验。
Clin Exp Med. 2024 Jan 19;24(1):7. doi: 10.1007/s10238-023-01280-1.
2
Predicting Fractures Using Vertebral 18F-NaF Uptake in Prostate Cancer Patients.利用18F-NaF在前列腺癌患者椎骨的摄取情况预测骨折
J Bone Metab. 2023 Nov;30(4):329-337. doi: 10.11005/jbm.2023.30.4.329. Epub 2023 Nov 30.
3
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
一项评估晚期前列腺癌骨矿物质密度变化的随机对照研究:促黄体生成素释放激素激动剂与经皮雌二醇的比较
Eur Urol. 2016 Jun;69(6):1016-25. doi: 10.1016/j.eururo.2015.11.030. Epub 2015 Dec 17.
4
The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.内皮素-1信号传导与犬骨肉瘤中骨碱性磷酸酶表达及促肿瘤活性的关联
J Vet Intern Med. 2015 Nov-Dec;29(6):1584-94. doi: 10.1111/jvim.13635. Epub 2015 Oct 1.
5
Diffuse osteosclerosis in a patient with prostate cancer.一名前列腺癌患者的弥漫性骨硬化。
Osteoporos Int. 2014 Mar;25(3):1181-5. doi: 10.1007/s00198-013-2545-9. Epub 2013 Oct 18.
6
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization.色素上皮衍生因子在干细胞/祖细胞相关新生血管形成中的作用。
J Biomed Biotechnol. 2012;2012:871272. doi: 10.1155/2012/871272. Epub 2012 May 22.